Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Stanford University
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Robert Lowsky, Stanford University
ClinicalTrials.gov Identifier:
NCT01523223
First received: January 27, 2012
Last updated: November 16, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)